• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

作为α1A -肾上腺素能受体拮抗剂的吲哚 - 芳基哌嗪衍生物的X射线晶体学、密度泛函理论计算及分子对接

X-ray Crystallography, DFT Calculations and Molecular Docking of Indole-Arylpiperazine Derivatives as α1A-Adrenoceptor Antagonists.

作者信息

Xu Wei, Huang Jun-Jun, Shao Bin-Hao, Xu Xing-Jie, Jiang Ren-Wang, Yuan Mu

机构信息

Pharmaceutical Research Center, Guangzhou Medical University, 195# Dongfengxi Road, Guangzhou 510182, China.

School of Pharmaceutical Sciences, Jinan University, Guangzhou 510632, China.

出版信息

Molecules. 2015 Oct 30;20(11):19674-89. doi: 10.3390/molecules201119651.

DOI:10.3390/molecules201119651
PMID:26528963
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6332402/
Abstract

Indole-arylpiperazine derivatives have exhibited good selectivity for the α1A-adrenoceptor, but the structure-activity-binding mechanism relationship remains unclear. In the current study, three compounds (1, 2 and 3) were investigated through single-crystal X-ray diffraction analysis, density functional theory (DFT) calculations and molecular docking using a homology model of the α1A receptor. Compounds 1 and 3 form H-bonds networks to stabilize their three-dimensional structures, while C-H···π interactions play a significant role in the packing of 2. Based on DFT-optimized conformations, the HOMO-LUMO energy gaps and molecular electrostatic potential (MEP) were theoretically calculated at the B3LYP/6-311G (d, p) level of theory. Chemical reactivity increases in the order of 3 < 2 < 1, and the maximum positive region of the MEP maps is mainly localized over the NH group. The binding mechanisms of ligand-α1A-adrenoceptor complexes were illustrated by molecular docking. Binding to Gln177 of the second extracellular loop region via hydrogen bonds is likely to be essential for α1A-selective antagonists. The present work sheds light on the studies of structure-activity-binding mechanism and aids in the design of α1A antagonists with high selectivity.

摘要

吲哚 - 芳基哌嗪衍生物对α1A - 肾上腺素能受体表现出良好的选择性,但构效关系与结合机制仍不清楚。在本研究中,通过单晶X射线衍射分析、密度泛函理论(DFT)计算以及使用α1A受体同源模型的分子对接,对三种化合物(1、2和3)进行了研究。化合物1和3形成氢键网络以稳定其三维结构,而C - H···π相互作用在化合物2的堆积中起重要作用。基于DFT优化的构象,在B3LYP/6 - 311G(d, p)理论水平上理论计算了最高占据分子轨道(HOMO)-最低未占据分子轨道(LUMO)能隙和分子静电势(MEP)。化学反应性按3 < 2 < 1的顺序增加,MEP图的最大正区域主要位于NH基团上。通过分子对接阐明了配体 - α1A - 肾上腺素能受体复合物的结合机制。通过氢键与第二个细胞外环区域的Gln177结合可能是α1A选择性拮抗剂的关键。本研究为构效关系与结合机制的研究提供了线索,并有助于设计具有高选择性的α1A拮抗剂。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c17/6332402/b4a7f544037a/molecules-20-19651-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c17/6332402/cac341833443/molecules-20-19651-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c17/6332402/ab6ceaf4c64a/molecules-20-19651-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c17/6332402/53f12ea89b72/molecules-20-19651-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c17/6332402/418f312ea8d8/molecules-20-19651-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c17/6332402/7f60ab04925c/molecules-20-19651-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c17/6332402/a91a678ea31d/molecules-20-19651-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c17/6332402/d00f9a7819b2/molecules-20-19651-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c17/6332402/11cb6640462d/molecules-20-19651-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c17/6332402/e67ffa295e43/molecules-20-19651-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c17/6332402/b9c71da59827/molecules-20-19651-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c17/6332402/475c5cf421ec/molecules-20-19651-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c17/6332402/b4a7f544037a/molecules-20-19651-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c17/6332402/cac341833443/molecules-20-19651-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c17/6332402/ab6ceaf4c64a/molecules-20-19651-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c17/6332402/53f12ea89b72/molecules-20-19651-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c17/6332402/418f312ea8d8/molecules-20-19651-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c17/6332402/7f60ab04925c/molecules-20-19651-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c17/6332402/a91a678ea31d/molecules-20-19651-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c17/6332402/d00f9a7819b2/molecules-20-19651-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c17/6332402/11cb6640462d/molecules-20-19651-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c17/6332402/e67ffa295e43/molecules-20-19651-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c17/6332402/b9c71da59827/molecules-20-19651-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c17/6332402/475c5cf421ec/molecules-20-19651-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c17/6332402/b4a7f544037a/molecules-20-19651-g012.jpg

相似文献

1
X-ray Crystallography, DFT Calculations and Molecular Docking of Indole-Arylpiperazine Derivatives as α1A-Adrenoceptor Antagonists.作为α1A -肾上腺素能受体拮抗剂的吲哚 - 芳基哌嗪衍生物的X射线晶体学、密度泛函理论计算及分子对接
Molecules. 2015 Oct 30;20(11):19674-89. doi: 10.3390/molecules201119651.
2
Synthesis, structure-activity relationship and biological evaluation of novel arylpiperzines as α1A/1D-AR subselective antagonists for BPH.新型芳基哌嗪作为用于良性前列腺增生的α1A/1D肾上腺素能受体亚型选择性拮抗剂的合成、构效关系及生物学评价
Bioorg Med Chem. 2015 Dec 15;23(24):7735-42. doi: 10.1016/j.bmc.2015.11.020. Epub 2015 Nov 19.
3
Design, synthesis, crystal structure, biological evaluation and molecular docking studies of carbazole-arylpiperazine derivatives.咔唑-芳基哌嗪衍生物的设计、合成、晶体结构、生物学评价及分子对接研究
Bioorg Med Chem. 2016 Nov 1;24(21):5565-5572. doi: 10.1016/j.bmc.2016.09.010. Epub 2016 Sep 13.
4
Design, synthesis and biological evaluation of new arylpiperazine derivatives bearing a flavone moiety as α1-adrenoceptor antagonists.设计、合成并评价含黄酮片段的新型芳基哌嗪衍生物作为α1-肾上腺素能受体拮抗剂。
Bioorg Med Chem Lett. 2011 Feb 1;21(3):909-11. doi: 10.1016/j.bmcl.2010.12.080. Epub 2010 Dec 21.
5
Synthesis and structure-activity relationships of novel arylpiperazines as potent antagonists of α1-adrenoceptor.新型芳基哌嗪作为α1-肾上腺素能受体强效拮抗剂的合成及构效关系
Eur J Med Chem. 2016 Oct 21;122:601-610. doi: 10.1016/j.ejmech.2016.06.052. Epub 2016 Jun 30.
6
Synthesis and SAR-study for novel arylpiperazine derivatives of 5-arylidenehydantoin with α₁-adrenoceptor antagonistic properties.新型 5-芳亚甲基海因-α1 肾上腺素受体拮抗作用的芳基哌嗪衍生物的合成及 SAR 研究。
Bioorg Med Chem. 2012 Jul 15;20(14):4245-57. doi: 10.1016/j.bmc.2012.05.064. Epub 2012 Jun 5.
7
Studies on novel pyridine and 2-pyridone derivatives of N-arylpiperazine as α-adrenoceptor ligands.新型N-芳基哌嗪吡啶和2-吡啶酮衍生物作为α-肾上腺素能受体配体的研究
Med Chem. 2014 Mar;10(2):144-53. doi: 10.2174/0929867320999131122114922.
8
Computational studies of the binding site of alpha1A-adrenoceptor antagonists.α1A-肾上腺素能受体拮抗剂结合位点的计算研究
J Mol Model. 2008 Oct;14(10):957-66. doi: 10.1007/s00894-008-0342-8. Epub 2008 Jul 15.
9
Orthosteric binding of ρ-Da1a, a natural peptide of snake venom interacting selectively with the α1A-adrenoceptor.与 α1A-肾上腺素受体选择性相互作用的蛇毒天然肽 ρ-Da1a 的正位结合。
PLoS One. 2013 Jul 25;8(7):e68841. doi: 10.1371/journal.pone.0068841. Print 2013.
10
Indolylpiperidine derivatives as potent and selective α1B adrenoceptor antagonists.吲哚基哌啶衍生物作为强效和选择性α1B肾上腺素能受体拮抗剂。
Bioorg Med Chem Lett. 2015 Sep 15;25(18):3921-3. doi: 10.1016/j.bmcl.2015.07.046. Epub 2015 Jul 22.

本文引用的文献

1
Design, Synthesis and Molecular Docking Studies of Novel Indole-Pyrimidine Hybrids as Tubulin Polymerization Inhibitors.新型吲哚 - 嘧啶杂化物作为微管蛋白聚合抑制剂的设计、合成及分子对接研究
Chem Biol Drug Des. 2015 Dec;86(6):1491-500. doi: 10.1111/cbdd.12616. Epub 2015 Aug 3.
2
Monoterpene indole alkaloid hydrazone derivatives with apoptosis inducing activity in human HCT116 colon and HepG2 liver carcinoma cells.在人HCT116结肠癌细胞和HepG2肝癌细胞中具有凋亡诱导活性的单萜吲哚生物碱腙衍生物。
Bioorg Med Chem Lett. 2015 Sep 1;25(17):3556-9. doi: 10.1016/j.bmcl.2015.06.084. Epub 2015 Jun 30.
3
Synthesis, Biological Evaluation and Molecular Modeling of Substituted Indeno[1,2-b]indoles as Inhibitors of Human Protein Kinase CK2.
作为人类蛋白激酶CK2抑制剂的取代茚并[1,2 - b]吲哚的合成、生物学评价及分子模拟
Pharmaceuticals (Basel). 2015 Jun 8;8(2):279-302. doi: 10.3390/ph8020279.
4
New indole-isoxazolone derivatives: Synthesis, characterisation and in vitro SIRT1 inhibition studies.新型吲哚-异恶唑酮衍生物:合成、表征及体外SIRT1抑制研究
Bioorg Med Chem Lett. 2015 Jul 15;25(14):2768-72. doi: 10.1016/j.bmcl.2015.05.015. Epub 2015 May 15.
5
Novel naftopidil-related derivatives and their biological effects as alpha1-adrenoceptors antagonists and antiproliferative agents.新型萘哌地尔相关衍生物及其作为α1-肾上腺素能受体拮抗剂和抗增殖剂的生物学效应。
Eur J Med Chem. 2015;96:83-91. doi: 10.1016/j.ejmech.2015.04.005. Epub 2015 Apr 7.
6
Synthesis, crystal structures and spectroscopic properties of triazine-based hydrazone derivatives; a comparative experimental-theoretical study.基于三嗪的腙衍生物的合成、晶体结构及光谱性质;一项对比性实验-理论研究。
Molecules. 2015 Apr 3;20(4):5851-74. doi: 10.3390/molecules20045851.
7
Synthesis and cytotoxic activity evaluation of novel arylpiperazine derivatives on human prostate cancer cell lines.新型芳基哌嗪衍生物对人前列腺癌细胞系的合成及细胞毒性活性评估
Molecules. 2014 Aug 12;19(8):12048-64. doi: 10.3390/molecules190812048.
8
An aspartate in the second extracellular loop of the α(1B) adrenoceptor regulates agonist binding.α(1B)肾上腺素能受体第二个细胞外环中的天冬氨酸调节激动剂结合。
Eur J Pharmacol. 2014 Jun 15;733:90-6. doi: 10.1016/j.ejphar.2014.03.034. Epub 2014 Mar 29.
9
Naftopidil for the treatment of benign prostate hyperplasia: a systematic review.萘哌地尔治疗良性前列腺增生:一项系统评价。
Curr Med Res Opin. 2014 Apr;30(4):719-32. doi: 10.1185/03007995.2013.861813. Epub 2013 Dec 18.
10
Studies on novel pyridine and 2-pyridone derivatives of N-arylpiperazine as α-adrenoceptor ligands.新型N-芳基哌嗪吡啶和2-吡啶酮衍生物作为α-肾上腺素能受体配体的研究
Med Chem. 2014 Mar;10(2):144-53. doi: 10.2174/0929867320999131122114922.